Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref. Design studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results

COVID 19 outpatients meta-analysis

PATCH Cohort 1 (Amaravadi)
 
NCT04329923
RCThydroxychloroquinestandard of careCOVID 19 outpatientssome concern
15/13 inconclusive
    BCN PEP-CoV-2-Study 2 (Mitja et al. Clin Infect Dis)
     
    NCT04304053
    RCThydroxychloroquinestandard of careCOVID 19 outpatientssome concern
    137/157 safety concern
    • statistically significant 25.5-fold increase in adverse events with a moderate degree of certainty due to some concern in risk of bias
    • statistically significant 177.2-fold increase in adverse events with a moderate degree of certainty due to some concern in risk of bias
    1 study excluded by filtering options (1 RCT / 0 OBS)

    PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
    Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).